Neuralink raises $600 million at a $9 billion valuation
Elon Musk’s brain-computer interface startup, Neuralink, has raised $600 million in a new funding round, pushing its pre-money valuation to $9 billion. The round marks a significant leap in valuation for the company, which was reportedly worth $5 billion less than a year ago.
The identities of the investors involved in this latest funding round have not been disclosed. This substantial influx of capital follows a $43 million venture raise in November 2023, and highlights Neuralink’s rapid growth as it sought to raise hundreds of millions more.
Founded with the vision of merging human brains with machines, Neuralink has been at the center of both technological ambition and ethical scrutiny. The startup is developing implantable brain devices designed to assist people with neurological conditions and, eventually, enhance human capabilities.
A key milestone in Neuralink’s journey came last year when the U.S. Food and Drug Administration granted the company “breakthrough device” designation, allowing accelerated development and testing. Since then, three individuals have received Neuralink implants.
Earlier this month, a major public moment highlighted the potential impact of the technology: a nonverbal patient, outfitted with a Neuralink implant, posted a video demonstrating how he uses only brain signals to edit and narrate YouTube content—an advancement that underscores the practical and life-altering implications of the device.
Neuralink did not respond to requests for comment outside regular business hours.
As the company enters this new phase of funding and development, the questions now shift from feasibility to scale. Can Neuralink commercialize its technology safely and ethically—and how quickly can it move from medical intervention to broader human enhancement?
The next few years will likely determine not only Neuralink's trajectory, but the public’s broader appetite for brain-machine integration.
